https://www.biopharmawatch.com/news/RXST/rxsight-inducement-grants-nasdaq-listing-rules BiopharmaWatch en 2026-07-26T20:00:00.000Z RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules https://www.biopharmawatch.com/news/NAMS/newamsterdam-pharma-chmp-recommendation-ubeslo-evlarco BiopharmaWatch en 2026-07-26T17:59:00.000Z NewAmsterdam Pharma und die Menarini Group erhalten positive Stellungnahme des CHMP mit der Empfehlung zur Erteilung einer Zulassung für Ubeslo® (Obicetrapib-Monotherapie) und Evlarco® (Festsatzkombination aus Obicetrapib und Ezetimib) https://www.biopharmawatch.com/news/OLMA/5gringos-registration-steps-norway BiopharmaWatch en 2026-07-26T16:13:06.000Z 5Gringos Registration Steps For Players In Norway https://www.biopharmawatch.com/news/OLMA/amazon-slots-registration-steps-belgian-players BiopharmaWatch en 2026-07-26T16:09:31.000Z Amazon Slots Registration Steps For Belgian Players https://www.biopharmawatch.com/news/OLMA/resolving-cashpot-login-issues-dutch-players BiopharmaWatch en 2026-07-26T15:38:54.000Z Resolving Cashpot Login Issues For Dutch Players https://www.biopharmawatch.com/news/OLMA/spinshouse-login-troubleshooting-netherlands-players BiopharmaWatch en 2026-07-26T15:32:46.000Z Spinshouse Login Troubleshooting For Netherlands Players https://www.biopharmawatch.com/news/OLMA/slots-eater-account-login-issues-guide BiopharmaWatch en 2026-07-26T14:24:15.000Z How To Fix SlotsEater Account Login And Access Issues https://www.biopharmawatch.com/news/OLMA/caxino-deposits-withdrawals-netherlands-payment-methods-fees BiopharmaWatch en 2026-07-26T14:00:02.000Z Caxino Deposits And Withdrawals In The Netherlands: Supported Payment Methods And Fees https://www.biopharmawatch.com/news/OLMA/slotexpress-welcome-bonus-wagering-requirements BiopharmaWatch en 2026-07-25T15:47:33.000Z SlotExpress Welcome Bonus Wagering Requirements Explained https://www.biopharmawatch.com/news/OLMA/pixelbet-welcome-bonus-sweden-conditions BiopharmaWatch en 2026-07-25T15:30:23.000Z Pixelbet Welcome Bonus In Sweden And Its Conditions https://www.biopharmawatch.com/news/OLMA/gamdom-login-verification-issues-uk BiopharmaWatch en 2026-07-25T14:17:25.000Z Resolving Gamdom Login And Verification Issues In The UK https://www.biopharmawatch.com/news/OLMA/gamdom-login-verification-issues-uk BiopharmaWatch en 2026-07-25T14:17:25.000Z Resolving Gamdom Login And Verification Issues In The UK https://www.biopharmawatch.com/news/OLMA/delicious-slots-login-problems-uk-fixes-solutions BiopharmaWatch en 2026-07-25T14:14:09.000Z Delicious Slots Login Problems In The United Kingdom: Fixes And Solutions https://www.biopharmawatch.com/news/PTHS/pelthos-therapeutics-2026-annual-meeting-stockholders BiopharmaWatch en 2026-07-24T21:05:45.922Z Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders https://www.biopharmawatch.com/news/HCSG/armor-health-lucas-county-corrections-center BiopharmaWatch en 2026-07-24T21:03:00.000Z Armor Health Selected to Provide Healthcare Services for the Lucas County Corrections Center in Toledo, Ohio https://www.biopharmawatch.com/news/NBP/novabridge-biosciences-agm-september-2026 BiopharmaWatch en 2026-07-24T21:00:00.000Z NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026 https://www.biopharmawatch.com/news/HCSG/pennyroyal-healthcare-data-incident-notice BiopharmaWatch en 2026-07-24T21:00:00.000Z Pennyroyal Healthcare Services Provides Notice of Data Incident https://www.biopharmawatch.com/news/MDXH/mdxhealth-nasdaq-notification-minimum-market-value-deficiency BiopharmaWatch en 2026-07-24T20:59:00.000Z Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency